-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Research Objectives:
Compare serum 25-OH-VitD levels in healthy children and children with epilepsy before and during treatment with antiepileptic drugs (ASMs), which is a major marker of vitamin D (VitD) status, and assess potential influencing factors
for 25-OH-VitD levels.
For comparison, we finally registered and collected data from 6,338 healthy children and 648 primary care pediatricians with epilepsy symptoms at the Children's Hospital of Nanjing Medical University from January 2019 to June 2021
.
Results of the study:
The serum 25-OH-VitD level was significantly lower in 648 children with epilepsy than in 6338 healthy children (P<0.
In this retrospective study, childhood epilepsy before and during the start of treatment with ASMs reduced serum concentrations of 25-OH-VitD, suggesting a clear link
between the risk of epilepsy and VitD deficiency.
References:
Dong N, Guo HL, Hu YH, Yang J, Xu M, Ding L, Qiu JC, Jiang ZZ, Chen F, Lu XP, Li XN.